Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 409 - 416 of 11440 results
New Mexico’s Health Care Consolidation Oversight Act: An Overview
March 11, 2024| Blog| Viewpoint
Northeastern Law Magazine Profiles Member Drew DeVoogd
March 9, 2024| News
How IP Lawyers Are Meeting Clients’ Patent Licensing Needs
March 8, 2024| News
How Can the Updated USPTO Guidance on Determining Obviousness Help You?
March 7, 2024| Blog| Viewpoint
Health Law Diagnosed – A Discussion on the Regulatory Requirements for LDTs
March 7, 2024| Podcast| Viewpoint
DOJ and FTC Weigh in on Alleged Algorithmic Price Fixing — AI: The Washington Report
March 7, 2024| Article| Viewpoint
FDA Faces Critical Deadlines in 2024, Even Without an Election Looming
March 6, 2024| Blog| Viewpoint
What’s New in Wireless - March 2024
March 6, 2024| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.